Industry Symposia
These sessions do not form part of the CME program.
In line with current regulations, medical students, patient advocates and patients will not be allowed access to the exhibition area or pharma supported symposia.
Wednesday, September 11, 2024
| 12:00-13:00 Hall A |
Industry Lunch Symposium: Treatment approaches to high risk early breast cancer Lilly sponsored symposium. Lilly products will be discussed at this symposium *Lunch boxes will be served to session participants prior to the session |
 |
Thursday, September 12, 2024
| 07:30-08:30 Hall A |
Breakfast Industry Symposium: What is the true utility of genomic testing in Early Breast Cancer? A closer look at intrinsic subtyping and Prosigna Supported by Veracyte *Light refreshments will be served prior to the session at 07:00 |
 |
| 07:30-08:30 Hall B |
Breakfast Industry Symposium: Sharing clinical experience with eligible women with HR+/HER2- advanced breast cancer – interactive case studies and panel discussions This promotional symposium has been organised and funded by Novartis Pharmaceuticals UK Ltd. Novartis products will be discussed at this symposium and prescribing information will be available from a Novartis representative during the symposium UK I August 2024 I FA-11253802 *Light refreshments will be served prior to the session at 07:00 |
 |
| 12:30-13:30 Hall A |
Pre-Lunch Industry Symposium: Push the paradigm: Advances in treating HER2-expressing metastatic breast cancer Sponsored by Daiichi Sankyo UK and AstraZeneca UK. This is a promotional symposium organised and funded by Daiichi Sankyo UK and AstraZeneca UK, at which Daiichi Sankyo and AstraZeneca products will be discussed within their UK Marketing Authorisations. |
 |
| 12:30-13:30 Hall B |
Pre-Lunch Industry Symposium: Clinical utility of the 7-gene predictive DCIS test to accurately stratify risk and predict radiation benefit vs. clinicopathologic tools alone Supported by PreludeDx |
 |
Friday, September 13, 2024
| 07:30-08:30 Hall B |
Breakfast Industry Symposium: The Great Axillary Debates: How do you surgically de-escalate Supported by Endomag *Light refreshments will be served prior to the session at 07:00 |
 |